Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors

Dimitris Karagiannis(Columbia University Irving Medical Center), Chao Lü(Columbia University Irving Medical Center)

Cell Reports

December 30, 2023

10.1016/j.celrep.2023.113629

Cited by 20

Related Papers

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

|Cancer Cell|2010|2.7k

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

|Cell|2022|216

Induction of sarcomas by mutant IDH2

|Genes & Development|2013|161

Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch

|Science Advances|2024|22

Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma

|Nature Communications|2023|18